Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract manufacturing and development of oral solid forms for the pharmaceutical and nutraceutical industries and in the cosmetic sector in Italy. The company offers pharmaceutical products, including powders, soluble, effervescent and chewable granules, filmed and effervescent tablets, fast melting/sublingual tablets, film-coated tablets… Read more
Fine Foods & Pharmaceuticals N.T.M. S.p.A. (9S5) - Net Assets
Latest net assets as of September 2025: €137.75 Million EUR
Based on the latest financial reports, Fine Foods & Pharmaceuticals N.T.M. S.p.A. (9S5) has net assets worth €137.75 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€261.73 Million) and total liabilities (€123.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €137.75 Million |
| % of Total Assets | 52.63% |
| Annual Growth Rate | -3.56% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5.59 |
Fine Foods & Pharmaceuticals N.T.M. S.p.A. - Net Assets Trend (2021–2024)
This chart illustrates how Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fine Foods & Pharmaceuticals N.T.M. S.p.A. (2021–2024)
The table below shows the annual net assets of Fine Foods & Pharmaceuticals N.T.M. S.p.A. from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €132.06 Million | +4.03% |
| 2023-12-31 | €126.95 Million | -4.76% |
| 2022-12-31 | €133.29 Million | -9.46% |
| 2021-12-31 | €147.22 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1427453900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €12.85 Million | 9.73% |
| Other Components | €119.21 Million | 90.27% |
| Total Equity | €132.06 Million | 100.00% |
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Competitors by Market Cap
The table below lists competitors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ample Electronic Technology Co Ltd
TWO:4760
|
$84.36 Million |
|
Delta Asia International Corporation
TWO:6762
|
$84.37 Million |
|
Baiksan
KO:035150
|
$84.37 Million |
|
Banque nationale de Belgique Société anonyme
BR:BNB
|
$84.38 Million |
|
NoiBai Cargo Terminal Services JSC
VN:NCT
|
$84.33 Million |
|
Chialin Precision Industrial Co Ltd
TWO:3310
|
$84.32 Million |
|
aTyr Pharma, Inc.
NASDAQ:ATYR
|
$84.27 Million |
|
Full House Resorts Inc
NASDAQ:FLL
|
$84.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 126,949,269 to 132,059,781, a change of 5,110,512 (4.0%).
- Net income of 8,155,879 contributed positively to equity growth.
- Dividend payments of 2,937,895 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €8.16 Million | +6.18% |
| Dividends Paid | €2.94 Million | -2.22% |
| Other Changes | €-107.47K | -0.08% |
| Total Change | €- | 4.03% |
Book Value vs Market Value Analysis
This analysis compares Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.65x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.47x to 1.65x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €6.07 | €8.90 | x |
| 2022-12-31 | €5.43 | €8.90 | x |
| 2023-12-31 | €5.18 | €8.90 | x |
| 2024-12-31 | €5.39 | €8.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fine Foods & Pharmaceuticals N.T.M. S.p.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.18%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.35%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 1.84x
- Recent ROE (6.18%) is above the historical average (-1.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -0.97% | -0.73% | 0.64x | 2.06x | €-16.15 Million |
| 2022 | -7.13% | -4.59% | 0.69x | 2.25x | €-22.83 Million |
| 2023 | -2.77% | -1.40% | 1.04x | 1.90x | €-16.22 Million |
| 2024 | 6.18% | 3.35% | 1.00x | 1.84x | €-5.05 Million |
Industry Comparison
This section compares Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,832,678,733,200
- Average return on equity (ROE) among peers: 0.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fine Foods & Pharmaceuticals N.T.M. S.p.A. (9S5) | €137.75 Million | -0.97% | 0.90x | $84.35 Million |
| COFCO Joycome Foods Limited (0M7) | $9.25 Billion | -0.10% | 0.76x | $482.93 Million |
| WH Group Ltd (0WH) | $9.69 Billion | 11.03% | 1.00x | $7.82 Billion |
| A2 Milk Company Ltd (14L) | $1.08 Billion | 7.44% | 0.27x | $4.22 Billion |
| HOCHDORF HLDG AG (1Z3) | $157.90 Million | -6.47% | 0.72x | $3.93 Million |
| PT Salim Ivomas Pratama Tbk (2IR) | $23.99 Trillion | 6.46% | 0.55x | $11.50 Million |
| DaChan Food (Asia) Limited (3DS) | $2.27 Billion | 6.85% | 0.52x | $17.89 Million |
| Global Sweeteners Holdings Limited (3GS) | $-218.25 Million | 0.00% | 0.00x | $2.66 Million |
| Meiji Holdings Co. Ltd (3M0) | $713.02 Billion | 12.27% | 0.57x | $5.87 Billion |
| Megmilk Snow Brand Co. Ltd (6MG) | $116.45 Billion | 2.21% | 1.87x | $839.43 Million |
| PT Eagle High Plantations Tbk (7B7) | $3.49 Trillion | -31.00% | 3.32x | $31.04 Million |